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Summary A cohort study was conducted to investigate the mortality of individuals employed by biological
research institutes in the UK. The inclusion criteria were met by 12703 individuals, of whom 95% were traced
(11 502 alive, 395 deaths, 246 embarkations). All-cause mortality was significantly reduced in men (standardised)
mortality ratio (SMR) 55 and women (SMR 52). Mortality was also significantly reduced for circulatory and
respiratory diseases, and overall there was low mortality from malignant neoplasms. SMRs exceeded 100, but
were not statistically significant, for infective and parasitic diseases. There were no statistically significant raised
SMRs for any cancer site. Workers were categorised as ever worked in a laboratory (laboratory workers) and
never worked in a laboratory (non-laboratory workers). The all-cause SMR was significantly reduced in both
groups, as was mortality from circulatory and respiratory diseases. The SMR for malignant neoplams was also
significantly reduced in laboratory workers. On the basis offollow-up to 31 December 1994, there is no evidence
of any overall increased risk ofmortality in biological research laboratory workers. However, the power of the
analysis is limited by the young age of many cohort members and short duration of follow-up. Follow-up is
continuing and the data will be reanalysed once more deaths have accumulated.
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Work in molecular biology entails exposure to a range of
hazards including ionising radiation, chemicals (some of
which are mutagenic and carcinogenic in animals and
humans) and infectious agents. During the 1980s a cluster
of rare cancers occurred among staff at the Institut Pasteur in
Paris (Cordier, 1990). All of the cases involved individuals
who were less than 50 years old and had been engaged in
biomedical research. This led the International Agency for
Research on Cancer (IARC) at the request of a group of
experts to initiate an international collaborative retrospective
cohort study of biological research workers looking
particularly at their risk of cancer (Sasco, 1992). This paper
reports on the initial findings on mortality in the British
component of the IARC study.
Materials and methods
The cohort was recruited from 24 institutes that had carried
out biological, biomedical or agronomic research as their
main activity, had operated for at least 10 years, and were
funded by national Research Councils or by charities (Table
I). The director ofeach institute was first approached and full
discussion took place with staff representatives at each
institute. All of the institutes had engaged in molecular
biology, except institute 12, which was administered through
institute 3 and was included to boost the number of
unexposed subjects for internal comparisons. One further
institute was invited to take part in the study but had to be
excluded because more than 10% of current staff refused
permission for their personnel records to be accessed. The
main activities carried out at the participating institutes are
listed in Table I. These were ascertained from the heads of
laboratories and other senior members of staff by means of a
short questionnaire.
To enter the cohort, a person had to have been employed
by one of the participating institutes at a time for which
personnel records were complete and to have worked at the
institute for more than a year after molecular biology started
(or after 1975 at institute 12). All such employees were
eligible for inclusion whatever their occupation. Visiting
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workers and students were excluded.
Subjects were identified from personnel records and their
occupational histories while at the relevant institute were
abstracted. The completeness of the information obtained
was checked by review of payroll records, staff lists and
annual reports and where this exercise identified people not
listed in personnel files, further checks were made. In most
cases the names of missing individuals appeared in only one
or two consecutive annual reports, suggesting that they had
worked for a relatively short time at that institute. When
subjects had worked at more than one of the participating
institutes, the records from each institute were collated. The
occupations recorded in personnel files were assigned to two
broad categories according to whether or not they entailed
work for more that 1 h per week in a laboratory. This
classification was again carried out with help from heads of
laboratories and senior staff. Staff working for more than 1 h
per week in a laboratory were designated as 'laboratory
workers' and the others as 'non-laboratory workers'.
The cohort was followed-up through the National Health
Service (NHS) Central Register, and death certificates were
obtained for subjects who had died up to 31 December 1994
with the underlying cause of death coded to the ninth
revision of the International Classification of Diseases (1CD-
9). Where subjects were difficult to trace at the NHS Central
Register, additional information was sought from Depart-
ment of Social Security records and this sometimes enabled
tracing to be completed.
The mortality of cohort members was compared with that
of the national population (England and Wales or Scotland
according to the location of the institute) by the person-
years method, with age and calendar period stratified in 5
year bands. Confidence intervals (CIs) for standardised
mortality ratios (SMRs) were based on the Poisson
distribution (Gardner et al., 1989).
In the analysis of mortality of laboratory workers and
non-laboratory workers, some individuals had experience in
both types of work. If the job entailing laboratory work
preceded the non-laboratory job, then all the person-years
were attributed to the laboratory work group. If the non-
laboratory work preceded the laboratory work, then person-
years in the non-laboratory post counted as non-laboratory,
while the succeeding person-years accrued to the laboratory
workers category. Thus, once an individual began work in
the laboratory all subsequent years accrued to that category.Mortality pattern of biological researchers
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Table I Details of participating institutes
Year personnel Year molecular Date of abstraction
records known biologyfirst ofpersonnel Main activities
Institute to be complete started records at institutea
1 1975 1982 May 1993 14,15,17,22
2 1978 1981 Jun. 1992 1,2,4,11,21,22
3 1963 1963 Jan. 1993 1,5,14,15,22
4 1975 1975 Feb. 1993 11,13,14,21,22
5 1975 1975 Feb. 1993 1,11,14,15,21,22
6 1970 1975 May 1992 11,13,15,19,22
7 1970 1980 Mar. 1993 12,13,19,22
8 1972 1985 May 1993 11,13,18,19,22
9 1963 1978 Dec. 1992 13,17,18,22
10 1971 1981 May 1993 6,11,12,17,19,22
11 1970 1984 Jun. 1992 11,13,19,22
12 1975 Feb. 1993
13 1980 1981 Jun. 1992 1,11,13,18,22
14 1962 1978 Jul. 1992 1,3,13,21
15 1980 1963 Jul. 1993 3,11,13,18
16 1980 1981 Mar. 1993 11,13,20,22
17 1965 1983 Jul. 1993 7,9,10,13,15,17,22
18 1965 1985 May 1993 1,2,3,13,22
19 1972 1966 Dec. 1991 8,11,15,22
20 1970 1980 Jan. 1992 11,13,19,21,22
21 1980 1989 Apr. 1993 11,13,21,22
22 1950 1981 May 1992 11,13,15,19,22
23 1965 1968 Apr. 1992 11,12,15,19,22
24 1968 1985 Nov. 1991 8,11,13,15,19,20,22
a 1, Bacteriology; 2, virology; 3, work with animal viruses; 4, chemical carcinogenesis/mutagenesis; 5, synthesis chemistry; 6, cytogenetics; 7,
transgenics; 8, oncogenic research; 9, polymerase chain reaction; 10, in situhybridisation; 11, tissueculture; 12, human orprimate tissueculture; 13,
work with live animals; 14, liquid chromatography; 15, gelelectrophoresis; 16, electronmicroscopy; 17, fluorescent lightmicroscopy/laser scanning;
18, immunoasssay (including ELISA); 19, work with human blood ortissues; 20, use ofethidium bromide; 21, work withcytotoxicdrugs; 22, work
with radioisotopes.
Table II Main causes of mortality in the cohort (follow-up to 31 December 1994)
Males Females Total
SMR 0 E SMR 0 E SMR
Causes ofdeath (ICD-9) 0 E (95%CI) (95%CI) (95%CI)
All causes 282 513.5 55 (49-62) 113 216.7 52 (43-63) 395 730.2 54 (49-60)
All malignant neoplasms (140-208) 99 145.4 68 (55-83) 62 80.9 77 (59-98) 161 226.3 71 (61-83)
Infective and parasitic diseases 4 2.6 154 (42-394) 2 1.2 167 (20-602) 6 3.8 158 (58-344)
(001-007, 010-139)
Endocrine, nutritional and metabolic 5 7.7 65 (21-152) 0 3.9 0 (0-95) 5 11.6 43 (14-101)
diseases (240-279)
Blood diseases (280-289) 0 0.9 0 (0-410) 2 0.6 333 (40-1200) 2 1.5 133 (16-482)
Mental disorders (290-315) 4 5.0 80 (22-205) 0 3.0 0 (0-123) 4 8.0 50 (14-128)
Diseases of the nervous system and sense 3 8.9 34 (7-99) 1 5.0 20 (1-111) 4 13.9 29 (8-74)
organs (320-389)
Circulatory diseases (390-459) 113 231.9 49 (40-59) 25 74.6 34 (22-50) 138 306.5 45 (39-53)
Ischaemic heart disease (410-414) 83 164.8 50 (40-62) 13 41.3 32 (17-54) 96 206.1 47 (38-57)
Cerebrovascular disease (430-438) 13 38.3 34 (18-58) 8 21.8 37 (16-72) 21 60.1 35 (22-53)
Respiratory diseases (460-519) 27 46.0 59 (39- 85) 7 17.0 41 (17-85) 34 63.0 54 (37-75)
Digestive diseases (008-009, 520-579) 5 15.3 33 (11-76) 3 8.2 37 (8-107) 8 23.5 34 (15-67)
Injuries and poisonings (800-999) 19 30.4 63 (38-98) 6 9.6 63 (23-136) 25 40.0 63 (40-92)
0, observed number of deaths; E, expected number ofdeaths; SMR, standardised mortality ratio.
Results
The search of personnel records identified 12842 subjects
who were eligible for entry to the cohort, including 340 who
had worked at more than one of the participating institutes.
Eighty-two of those currently employed at the time of data
abstraction declined to participate and were excluded from
the analysis, as were 57 subjects with unknown date of birth,
sex or date of first employment.
Of the remaining 12703 subjects (6367 men and 6336
women), 12143 (95.6%) were successfully traced at the NHS
Central Register. Of these 11 502 were alive at 31 December
1994, 395 had died and 246 were known to have left the
country. The latter were considered at risk up to the date of
their emigration. Follow-up of the 560 subjects who could
not be traced was censored at their date of last known
employment. At the time of data abstraction 4600 were still
in employment at one of the institutes and 1072 were known
to have retired.
Overall mortality in the cohort was well below that
expected from national death rates (SMR 55, 95% CI 49-62
in men; SMR 52, 95% CI 43-63 in women). This was
attributable largely to deficits in deaths from cancer and
circulatory disease (Table II). There was a small excess of
deaths from infective and parasitic diseases (SMR 158, six
deaths), but this was not statistically significant.
Table III shows mortality from specific types of cancer.
SMRs were elevated for cutaneous melanoma (four deaths),
other skin cancers (two deaths), and cancers of the uterine
body (two deaths), thyroid (two deaths), myeloma (four
deaths) and leukaemia (seven deaths). However, none of
these- increases was statistically significant.Mortality pattern of biological researchers
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Table IV shows mortality from selected causes according
to whether or not people had worked in laboratories for
more than 1 h per week. The total numbers of deaths for
some causes in this table do not correspond to the totals in
Tables II and III because we were not able to categorise the
job titles of some individuals. In general, death rates tended
to be lower in laboratory workers than in other members of
the cohort. Four deaths from infective and parasitic diseases
occurred in laboratory staff (2.4 deaths expected), two of
which were from viral hepatitis.
Discussion
This study was restricted to research institutes funded by
charities and by national research councils. University
departments were excluded because it would have been
more difficult to identify relevant personnel from the records
available. All but one of the institutes that we approached
were included in the study. The single exclusion occurred
because more than 10% of current staff declined to
participate in the investigation. This decision was not related
to known or perceived patterns of mortality or morbidity at
the institute concerned and should not have led to any
important bias.
Ascertainment of the cohort was complicated by the
differences in organisation of personnel records at the various
participating institutes. However, checks that we were able to
carry out suggested that almost all of the subjects eligible for
study were identified. In a few cases the information in
personnel files was inadequate for analysis, but this reflected
standards of record-keeping at the time the subjects were
employed and again should not have produced important
bias.
Among the subjects with adequate personnel records, the
trace-rate of 95%, although adequate, was rather lower than
in most industrial cohort studies. This may be because
laboratory staff are more mobile. For example, some may
have come from and returned overseas without registering
with a doctor while in Britain. If so, they would not be
included in the NHS Central Register.
As in other studies of chemists and laboratory workers,
Table III Mortality from malignant neoplasms (follow-up to 31 December 1994)
Males Females Total
Cause ofdeath (ICD-9) 0 E SMR(95%CI) 0 E SMR(95%CI) 0 E SMR(95%CI)
Cancer of gastrointestinal tract 22 30.1 73 (46-111) 6 11.4 53 (19-115) 28 41.5 68 (45-98)
(140- 154)
Cancer of liver (155) 2 1.5 133 (16-482) 0 0.6 0 (0-615) 2 2.1 95 (12-344)
Cancer of pancreas (157) 6 6.1 98 (36-214) 0 2.9 0 (0-127) 6 9.0 67 (25-145)
Cancer of larynx (161) 1 1.4 71 (2-398) 0 0.2 0 (0-1840) 1 1.6 63 (2-348)
Cancer of lung (162) 31 51.3 60 (41-86) 9 12.9 70 (32-132) 40 64.2 62 (45-85)
Cancer of connective tissue (171) 1 0.7 143 (4-796) 0 0.4 0 (0-922) 1 1.1 91 (2-507)
Malignant melanoma (172) 2 1.5 133 (16-482) 2 1.0 200 (24-722) 4 2.5 160 (44-410)
Other skin cancers (173) 1 0.4 250 (6-1390) 1 0.1 1000 (25-5570) 2 0.5 400 (48-1440)
Cancer of breast (174) 21 20.8 101 (63-154) 21 20.8 101 (63-154)
Cancer of genitourinary tract 12 15.5 77 (40- 135) 8 12.0 67 (29- 131) 20 27.5 73 (44-112)
(179- 189)
Cancer of prostate (185) 9 9.7 93 (43- 176) 9 9.7 93 (43-176)
Cancer of uterine body (182) 2 1.1 182 (22-657) 2 1.1 182 (22-657)
Cancer of brain (191-192) 3 4.5 67 (14-195) 2 2.3 87 (11-314) 5 6.8 74 (24-172)
Cancer of thyroid (193) 1 0.2 500 (13-2790) 1 0.2 500 (13-2790) 2 0.4 500 (61-1810)
Lymphohaematopoietic cancer 8 8.9 90 (39-177) 6 4.3 140 (51-304) 14 13.2 106 (58-178)
(200-208)
NHL (200, 202-202.1, 202.8) 2 3.9 51 (6-185) 1 1.9 53 (1-293) 3 5.8 52 (11-151)
Multiple myeloma (203) 3 1.9 158 (33-461) 1 0.9 111 (3-619) 4 2.8 143 (39-366)
Leukaemia (204-208) 3 3.9 77 (16 225) 4 1.9 211 (57-539) 7 5.8 121 (49-249)
Other cancersa 9 6 15
aSecondary malignant neoplasms ofother specified sites(1 male, 1 female); Malignant neoplasm withoutspecification ofsite (8 males, 5 females).
0, observed number ofdeaths; E, expected number ofdeaths; SMR, standardised mortality ratio; NHL, non-Hodgkin's lymphoma.
Table IV Mortality from selected causes by job category
Mortality
Ever worked in a laboratorya Never worked in a laboratory
Cause ofdeath 0 SMR (95% CI) 0 SMR (95% CI)
All causes 192 46 (40-53) 199 66 (57-76)
All malignant neoplasms 74 57 (45-72) 86 84 (67-104)
Cancer of gastrointestinal 14 59 (32-99) 13 71 (38-121)
tract
Cancer of pancreas 5 98 (32-229) 1 25 (1-139)
Cancer of genitourinary 6 40 (15-87) 14 111 (61-186)
tract
Cancer of brain 4 87 (24-223) 1 37 (1-206)
Lymphohaematopoietic 9 111 (51-211) 5 94 (31 -220)
cancer
Infective and parasitic 4 160 (44-410) 2 133 (16-482)
diseases
Circulatory diseases 66 39 (30-49) 71 56 (43-70)
Respiratory diseases 14 44 (24-74) 19 78 (47-122)
Injuries and poisonings 18 53 (31-83) 7 53 (21-109)
aMore than 1 h per week. 0, observed number ofdeaths; SMR, standardised mortality ratio.Mortalty pattern of boogc resedcers
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overall mortality in our cohort was well below that in the
national population (Li et al., 1969; Hoar and Pell, 1981;
Cordier, 1990; Belli et al., 1992; Hunter et al., 1993). In
addition to the normal 'healthy worker effect' from selective
exclusion of chronically disabled people from employment, it
is likely that the study population had an unusually healthy
lifestyle. For example, the deficit of deaths from lung cancer
(SMR 62) suggests a low prevalence of smoking. If anything,
cohort members who had worked in laboratories had lower
mortality than those who had not (Table IV).
The shortfall in deaths from lung cancer contnrbuted to
low mortality from cancer. As would be expected, a few
specific cancers occurred in excess, although not to the point
of statistical significance. In general, these were not tumours
that have been linked with laboratory work previously. The
cluster ofcancers at the Institut Pasteur which stimulated our
investigation comprised tumours of the brain, pancreas and
bone (Cordier, 1990). Subsequently, a cohort study at the
Instituto Superiore di Sanita in Rome found excesses of
brain, pancreatic and lymphohaematopoietic cancers (Beffi et
al., 1992). In the UK, analysis of cancer registrations among
chemists, physical or biological scientists and laboratory
assistants showed a small excess of brain and nervous system
cancers, but was otherwise unremarkable (Carpenter et al.,
1991). Two studies of people working in agricultural research
have indicated increased risks of lymphoma and cancer of the
colon, and of brain, bladder and heamatopoietic cancer
(Dosemeci et al., 1992; Daly et al., 1994). In our study
elevated mortality was observed from malignant melanoma,
other skin cancer, cancers of the uterine body and thyroid,
multiple myeloma and leukaemia, but none of these was
statistically significant. Among the subset ofsubjects who had
worked for more than 1 h per week in a laboratory, deaths
from lymphohaematopoietic cancer were close to expectation.
Examination ofthe occupational histories of the two subjects
who died of thyroid cancer, revealed that one was categorised
as a laboratory worker and the other had never worked in a
laboratory. There was nothing in the available records to
suggest an occupational cause for their illness.
Six members of the cohort died from infective or parasitic
disease as compared with 3.8 expected. Four of these deaths
were known definitely to be in laboratory workers (2.4
expected), of which two were from viral hepatitis, and
occurred in men who had worked in laboratories where
viruses were handled. We do not know whether their jobs
entailed contact with hepatitis viruses.
Overall, the findings of this study are reassuring, with no
evidence of any important increase in mortality from cancer.
However, the power of the analysis is limited by the young
age of many cohort members and relatively short duration of
follow-up. Furthermore, the effects of a hazard may have
been obscured if only a small proportion of subjects were
exposed to it. The patterns of exposure in the cohort are
complex and will be described in a separate paper. At this
stage, however, there are too few deaths to warrant a detailed
analysis by exposure. Such analysis should become possible
with continued follow-up and when findings are combined
with those from the other parallel studies being coordinated
by IARC.
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